DOCSLIB.ORG

Sensitivity and Flexibility for Detecting HPV in Cervical Biopsy Specimens and Cell Lines

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sensitivity and Flexibility for Detecting HPV in Cervical Biopsy Specimens and Cell Lines J Clin Pathol 1991;44:33-38 33 Interphase cytogenetics using biotin and digoxigenin labelled probes: III Increased J Clin Pathol: first published as 10.1136/jcp.44.1.33 on 1 January 1991. Downloaded from sensitivity and flexibility for detecting HPV in cervical biopsy specimens and cell lines C S Herrington, A K Graham, J O'D McGee Abstract background to the same extent as biotin. A monoclonal antibody to digoxin en- Digoxigenin labelled probes, however, are less abled sandwich techniques to be used for sensitive than biotinylated probes using single the detection of hybridised digoxigenin step detection methods.6 The sensitivity of labelled probes in cultured cells and detection procedures can be enhanced using paraffin wax sections. This system has antibody sandwich techniques using a linker greater flexibility than alkaline phos- antibody to bridge between antibody directed phatase conjugated polyclonal anti- against reporter molecule and an enzyme con- digoxigenin antibody and permits the jugate.9 A refinement of this concept is to use use of alternative detector enzymes, such biotinylated antibodies, which can be used to as horseradish peroxidase and fluores- bridge between the first antibody, and an cence labels. The APAAP detection avidin enzyme conjugate.'0 This gives system that does not require the use of increased sensitivity due to the high affinity of biotin can also be used in situations avidin for biotin (dissociation constant = I0-` where endogenous biotin is a problem. M) and improved specificity when the first The low level of background staining antibody is of monoclonal type. combined with precise substrate deposi- Digoxigenin, the aglycone derivative of the tion of the amplified peroxidase system cardiac glycoside digoxin, has high affinity for gives higher sensitivity and resolution. antibodies to digoxin."'3 This suggested to us This permits localisation of closely that the antibodies which have been adjacent chromosomal loci in interphase developed for the monitoring and treatment of nuclei. The most sensitive peroxidase clinical digoxin toxicity would increase the http://jcp.bmj.com/ based digoxigenin detection system sensitivity of detection of digoxigenin labelled visualises two and a half to 12 copies of probes in NISH. human papillomavirus (HPV) per The aims of this investigation were: (1) to nucleus. This system is also suitable for develop systems of high sensitivity and the analysis of low copy number HPV resolution for digoxigenin labelled probes infection of cervical tissues. which are applicable to interphase cyto- genetics-for the latter, CaSki and HeLa cells on September 30, 2021 by guest. Protected copyright. were used as a model system; and (2) to adapt Interphase cytogenetics encompasses, among detection systems for digoxigenin labelled other things, visual discrimination of probes so that they are more sensitive and individual chromosomes or genes in inter- flexible for detection of genes in archival phase nuclei.'-3 This has previously been biopsy specimens. performed by fluorescence45 and more recently by enzyme based chromogenic procedures using biotin and digoxigenin Methods labelled probes.' During the course of the All chemicals were obtained from Sigma (UK) latter work, it became apparent that the detec- or BDH (UK) unless otherwise stated. tion systems for biotin or digoxigenin labelled The HPV6 probe was the amp2 fragment probes using alkaline phosphatase based cloned into pBR322,'4 the HPV16 probe the detection systems did not give sufficient whole viral genome in pAT153,'5 and HPV18 resolution to discriminate between closely 16 University of Oxford the whole viral genome in pBR322. Biotin and Nuffield Department adjacent chromosomal loci. digoxigenin were incorporated into plasmid of Pathology and Digoxigenin labelled probes have been used DNAs by nick translation, and the degree of Bacteriology, John both as alternatives and in addition to biotin Radcliffe Hospital, labelling and size of fragments were as Headington, Oxford labelled probes in non-isotopic in situ previously described.6 17 OX3 9DU hybridisation (NISH).67 The main advantage Paraffin wax sections were prepared and C S Herrington of digoxigenin over biotin labelled probes for nucleic acids unmasked as previously A K Graham NISH is that digoxigenin (a plant alkaloid J O'D McGee described.6 analogue), unlike biotin, is not present con- Correspondence to: HeLa 229 cells (ATCC, USA) were grown to Professor McGee stitutively in mammalian cells. Hence, in confluence in 80 cm2 flasks in RPMI 1640 Accepted for publication immunohistochemical detection systems, medium (Gibco, UK) supplemented with L- 16 August 1990 digoxigenin does not generate endogenous glutamine (1 x; Gibco, UK); penicillin/ 34 Herrington, Graham, McGee streptomycin (1 x; Gibco, UK); and 20% fetal diluted 1 in 600 in TBT, washed in TBS, and calf serum (Gibco, UK). Detachment was the signal was developed using NBT/BCIP achieved using trypsin/EDTA solution (see below). (Gibco, UK) and the cells were pelleted at (b) Three step procedure Sections were J Clin Pathol: first published as 10.1136/jcp.44.1.33 on 1 January 1991. Downloaded from 600 x g. After two washes in PBS the cells incubated in monoclonal antidigoxin (Sigma, were fixed in 10% formalin, embedded in agar, UK) diluted 1 in 10 000 in TBT. Subsequent and processed to paraffin wax in the usual way. detection was as for the three step detection of Sections of 4 ,gm were cut and unmasked using biotinylated probes, with second incubation in proteinase K at a concentration of 1 mg/ml in biotinylated rabbit anti-mouse (F(ab')2 frag- PBS for 15 minutes at 37°C. ment) and the third incubation in avidin- CaSki cells were grown onto slides, fixed in peroxidase (dig-3-P/C) or avidin-alkaline paraformaldehyde, and nucleic acids unmasked phosphatase (dig-3-A/N). as previously described.6 (c) APAAP system Slides were incubated in monoclonal a4tidigoxin as in (a), followed by HYBRIDISATION rabbit anti-mouse immunoglobulin (Dako, Aliquots of hybridisation mix (8 u1) containing UK), diluted 1 in 50 in TBT, then APAAP 2 ng/pl ofbiotin or digoxigenin labelled HPV6, complex (Dako, UK) diluted 1 in 50 in TBT. HPV 16, or HPV18 were added to each well on Signal was developed using NBT/BCIP. multispot slides which were covered with a (d) Fluorescence detection Slides were treated 14 mm glass coverslip (Chance, UK) and the as for the three step detection method in (b) slides placed in a moist Terasaki plate. except that streptavidin-fluorescein iso- Hybridisation mix consisted of 50% forma- thiocyanate (Dako, UK) was used in the final mide, 5% dextran sulphate, 2 x SSC, and 0 05 step. Optimal results were obtained with a mol/l TRIS-HCI, pH 7 3; 1 x SSC = 0 15 dilution of .1 in 20 of the fluorescent conjugate mol/l sodium chloride, 0-015 mol/l sodium in TBT containing 5% non-fat milk. citrate. Sections and probes were simul- taneously denatured at 95°C for 15 minutes on a SUBSTRATE PREPARATION solid stainless steel plate in a hot air oven and Nitrobluoe tetrazolium/5-bromo-4-chloro- then hybridised at 420C for 2 hours. 3-indolyl phosphate (NBT/BCIP) and amino- ethylcarbazole (AEC) were made as previously DETECTION OF HYBRIDISATION SIGNAL described.618 Diaminobenzidine (DAB) was All antibody/avidin incubations were carried diluted to 0-5 mg/ml in distilled water and out for 30 minutes at 22°C unless otherwise stored in 5 ml aliquots at -20°C. Hydrogen stated. Slides were washed in three changes of4 peroxide was added to DAB (final concentra- x SSC at 22°C (five minutes each change), tion 03%) immediately before use. After probe soaked in blocking agent TBT (0.05 mol/l detection slides were air dried at 42°C and mounted in TRIS-HCI, 0-10 mol/l sodium chloride (pH glycerol jelly (for enzyme/ http://jcp.bmj.com/ 7 2) containing 3% (w/v) bovine serum chromogen reactions). For fluorescence albumin and 0-05% Triton 100 (v/v)) at 22°C preparations, PBS/glycerol (1:9 v/v) contain- for 10 minutes. Subsequent visualisation of ing 2-3% diazobicyclo-octane (DABCO) signal was determined by the reporter (Sigma, UK) was used. molecule. Frequency distributions were compared using the two tailed Mann-Whitney U test with Biotin labelled probes a correction for tied values. on September 30, 2021 by guest. Protected copyright. (a) Single step procedure Sections were incubated in avidin-alkaline phosphatase or avidin-peroxidase (Dako, UK) diluted 1 in 100 Results in TBT. Unbound conjugate was removed by The results of single step detection methods for washing for five minutes twice in 50 mM biotin and digoxigenin probes have previously TRIS-HCI, 10 mM NaCl, pH 7 2 (TBS), and been reported.67 These were less sensitive than the sections incubated in the appropriate the three step procedures described below. substrate. (b) Three step procedure Sections were COMPARATIVE SENSITIVITY AND RESOLUTION OF incubated first in monoclonal mouse anti- DIGOXIGENIN AND BIOTIN IN INTERPHASE CELLS biotin (Dako, UK) diluted 1 in 50 in TBT, The three step peroxidase AEC detection washed in TBS (twice at 10 minutes each), and method for digoxigenin labelled probes (dig-3- then in biotinylated rabbit anti-mouse (F(ab')2 P/C) produced very low background staining fragment, Dako, UK). After washing in TBS, and enhanced resolution in CaSki and HeLa the third incubation was in either avidin alka- cells (figs 1 and 2). Discrete HPV signals were line phosphatase (bio-3-A/N), or streptavidin considerably more easily resolved when com- peroxidase (Dako, UK) (bio-3-P/C). The pared with the three step alkaline phosphatase former was diluted 1 in 50 and the latter 1 in NBT/BCIP detection system for digoxigenin 100 in TBT containing 5% non-fat milk. After (dig-3-A/N) (fig 1); the latter is the counterpart washing in TBS, sections were incubated in the ofthe most sensitive system we have developed appropriate substrate (see below).
Load more

Recommended publications
  • Cardenolide Biosynthesis in Foxglove1
    Review 491 Cardenolide Biosynthesis in Foxglove1 W. Kreis2,k A. Hensel2, and U. Stuhlemmer2 1 Dedicated to Prof. Dr. Dieter He@ on the occasion of his 65th birthday 2 Friedrich-Alexander-Universität Erlangen, Institut für Botanik und Pharmazeutische Biologie, Erlangen, Germany Received: January 28, 1998; Accepted: March 28, 1998 Abstract: The article reviews the state of knowledge on the genuine cardiac glycosides present in Digitalis species have a biosynthesis of cardenolides in the genus Digitalis. It sum- terminal glucose: these cardenolides have been termed marizes studies with labelled and unlabelled precursors leading primary glycosides. After harvest or during the controlled to the formulation of the putative cardenolide pathway. Alter- fermentation of dried Digitalis leaves most of the primary native pathways of cardenolide biosynthesis are discussed as glycosides are hydrolyzed to yield the so-called secondary well. Special emphasis is laid on enzymes involved in either glycosides. Digitalis cardenolides are valuable drugs in the pregnane metabolism or the modification of cardenolides. medication of patients suffering from cardiac insufficiency. In About 20 enzymes which are probably involved in cardenolide therapy genuine glycosides, such as the lanatosides, are used formation have been described "downstream" of cholesterol, as well as compounds obtained after enzymatic hydrolysis including various reductases, oxido-reductases, glycosyl trans- and chemical saponification, for example digitoxin (31) and ferases and glycosidases as well as acyl transferases, acyl es- digoxin, or chemical modification of digoxin, such as metildig- terases and P450 enzymes. Evidence is accumulating that car- oxin. Digitalis lanata Ehrh. and D.purpurea L are the major denolides are not assembled on one straight conveyor belt but sources of the cardiac glycosides most frequently employed in instead are formed via a complex multidimensional metabolic medicine.
    [Show full text]
  • Quo Vadis Cardiac Glycoside Research?
    toxins Review Quo vadis Cardiac Glycoside Research? Jiˇrí Bejˇcek 1, Michal Jurášek 2 , VojtˇechSpiwok 1 and Silvie Rimpelová 1,* 1 Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, Prague 6, Czech Republic; [email protected] (J.B.); [email protected] (V.S.) 2 Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 3, Prague 6, Czech Republic; [email protected] * Correspondence: [email protected]; Tel.: +420-220-444-360 Abstract: AbstractCardiac glycosides (CGs), toxins well-known for numerous human and cattle poisoning, are natural compounds, the biosynthesis of which occurs in various plants and animals as a self-protective mechanism to prevent grazing and predation. Interestingly, some insect species can take advantage of the CG’s toxicity and by absorbing them, they are also protected from predation. The mechanism of action of CG’s toxicity is inhibition of Na+/K+-ATPase (the sodium-potassium pump, NKA), which disrupts the ionic homeostasis leading to elevated Ca2+ concentration resulting in cell death. Thus, NKA serves as a molecular target for CGs (although it is not the only one) and even though CGs are toxic for humans and some animals, they can also be used as remedies for various diseases, such as cardiovascular ones, and possibly cancer. Although the anticancer mechanism of CGs has not been fully elucidated, yet, it is thought to be connected with the second role of NKA being a receptor that can induce several cell signaling cascades and even serve as a growth factor and, thus, inhibit cancer cell proliferation at low nontoxic concentrations.
    [Show full text]
  • Custom Oligonucleotide Modifications Guide
    3050 Spruce Street, St. Louis, MO 63103 USA Tel: (800) 521-8956 (314) 771-5765 Fax: (800) 325-5052 (314) 771-5757 Custom Oligonucleotide Modifications Guide These are some of the 200 modifications that Sigma offers for both DNA and RNA oligonucleotides and probes. If you do not see the mod you require, we will order it for you. 1 Table of Contents ATTACHMENT ............................................................................................................................................................... 4 AMINO MODIFIERS ........................................................................................................................................................ 4 5′-DMS(O)MT-Amino-Modifier-C6 ...................................................................................................................... 4 5′-Amino-Modifier-C3-TFA .................................................................................................................................. 5 5′-Amino-Modifier-C12 ......................................................................................................................................... 6 5′-Amino-Modifier-C6-TFA (trifluoroacetic acid protecting group on amine) ...................................................... 7 5′-Amino-dT ........................................................................................................................................................... 8 5′-Amino-Modifier-5 .............................................................................................................................................
    [Show full text]
  • The Foxgloves (Digitalis) Revisited*
    Reviews The Foxgloves (Digitalis) Revisited* Author Wolfgang Kreis Affiliation Supporting information available online at Lehrstuhl Pharmazeutische Biologie, Department Biology, http://www.thieme-connect.de/products FAU Erlangen-Nürnberg, Erlangen, Germany ABSTRACT Key words Digitalis, Plantaginaceae, cardiac glycosides, plant biotech- This review provides a renewed look at the genus Digitalis. nology, biosynthesis, plant tissue culture, phylogeny Emphasis will be put on those issues that attracted the most attention or even went through paradigmatic changes since received March 17, 2017 the turn of the millennium. PubMed and Google Scholar were “ ” “ ” revised April 27, 2017 used ( Digitalis and Foxglove were the key words) to iden- accepted May 8, 2017 tify research from 2000 till 2017 containing data relevant enough to be presented here. Intriguing new results emerged Bibliography from studies related to the phylogeny and taxonomy of the DOI https://doi.org/10.1055/s-0043-111240 genus as well as to the biosynthesis and potential medicinal Published online May 23, 2017 | Planta Med 2017; 83: 962– uses of the key active compounds, the cardiac glycosides. 976 © Georg Thieme Verlag KG Stuttgart · New York | Several Eastern and Western Foxgloves were studied with re- ISSN 0032‑0943 spect to their propagation in vitro. In this context, molecular biology tools were applied and phytochemical analyses were Correspondence conducted. Structure elucidation and analytical methods, Prof. Dr. Wolfgang Kreis which have experienced less exciting progress, will not be Department Biology, FAU Erlangen-Nürnberg considered here in great detail. Staudtstr. 5, 91058 Erlangen, Germany Phone:+4991318528241,Fax:+4991318528243 [email protected] Taxus species is a prime example [4].
    [Show full text]
  • Profiling and Structural Analysis of Cardenolides in Two Species of Digitalis Using Liquid Chromatography Coupled with High-Resolution Mass Spectrometry
    bioRxiv preprint doi: https://doi.org/10.1101/864959; this version posted December 5, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Profiling and structural analysis of cardenolides in two species of Digitalis using liquid chromatography coupled with high-resolution mass spectrometry Baradwaj Gopal Ravi1†, Mary Grace E. Guardian2†, Rebecca Dickman2, Zhen Q. Wang1* 1Department of Biological Sciences, University at Buffalo, State University of New York, Buffalo, NY 14260, United States 2Department of Chemistry, Chemistry Instrumentation Center, University at Buffalo, State University of New York, Buffalo, NY 14260, United States †These authors contributed equally to this work. *Correspondent author: Tel: (+1)7166454969 [email protected] Keywords: cardiac glycoside; foxglove; Digitalis purpurea; Digitalis lanata; digoxin; digitoxin Abstract Plants of the Digitalis genus contain a cocktail of cardenolides commonly prescribed to treat heart failure. Cardenolides in Digitalis extracts have been conventionally quantified by high- performance liquid chromatography yet the lack of structural information compounded with possible co-eluents renders this method insufficient for analyzing cardenolides in plants. The goal of this work is to structurally characterize cardiac glycosides in fresh-leaf extracts using liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) that provides exact masses. Fragmentation of cardenolides is featured by sequential loss of sugar units while the steroid aglycon moieties undergo stepwise elimination of hydroxyl groups, which distinguishes different aglycones. The sequence of elution follows diginatigenindigoxigeningitoxigeningitaloxigenindigitoxigenin for cardenolides with the same sugar units but different aglycones using a reverse-phase column.
    [Show full text]
  • Sensitivity of Digoxigenin and Biotin Labelled
    800 J Clin Pathol 1990;43:800-805 Sensitivity of digoxigenin and biotin labelled probes for detection of human papillomavirus by J Clin Pathol: first published as 10.1136/jcp.43.10.800 on 1 October 1990. Downloaded from in situ hybridisation R G Morris, M J Arends, P E Bishop, K Sizer, E Duvall, CC Bird Abstract ing of streptavidin to endogenous sites within The sensitivity of digoxigenin and biotin tissues.'3 '4 As a putatively more sensitive labelled DNA probes for the detection of alternative, digoxigenin, a derivative of the human papillomavirus (HPV) by dot cardiac glycoside digoxin, has recently been blotting and in situ hybridisation was used to label DNA probes for the successful compared in tissues from cervical, identification of HPV in HeLa and SiHa laryngeal, and anogenital neoplasia. cells."5 Probes were either labelled with digox- igenin by the random primer technique and detected with anti-digoxigenin Methods antibody, or labelled with biotin by nick TISSUE PREPARATION translation and detected with strep- Procedures were adapted from the method of tavidin, both methods having a common Lewis et al.'2 Paraffin wax sections (5 gm) final visualisation procedure using alk- were prepared from routinely processed aline phosphatase. Digoxigenin labelled paraffin wax blocks and placed on 3-amino- probes proved two to 10-fold more sen- propyltriethoxysilane (TESPA; Sigma) coated sitive by quantitative dot blotting and slides'6 and incubated at 42°C for three days four-fold more sensitive in detecting before dewaxing in xylene at 37°C for 30 HPV 16 DNA in a series of 31 anal car- minutes and xylene at room temperature for cinomas, compared with biotinylated 10 minutes.
    [Show full text]
  • Chemical Structure and Pharmacological Activity of Some Derivatives of Digitoxigenin and Digoxigenin
    Brit. J. Pharmacol. (1962), 18, 311-324. CHEMICAL STRUCTURE AND PHARMACOLOGICAL ACTIVITY OF SOME DERIVATIVES OF DIGITOXIGENIN AND DIGOXIGENIN BY B. T. BROWN, ANNE STAFFORD* AND S. E. WRIGHT From the Departments of Pharmacy and Pharmacology, University of Sydney (Received December 13, 1961) A series of derivatives of digitoxigenin and digoxigenin were prepared and tested for toxicity in the cat and the guinea-pig and on the isolated heart of the 48-hr chick embryo, and for inotropic activity on the cat isolated papillary muscle and the guinea-pig Langendorff heart. The order of relative potency of the compounds remained the same whether they were tested for toxicity or for positive inotropic activity. There are three molecular centres in the cardiac aglycone that are linked closely with cardiac activity. These are: (a) an OH at carbon-3 which can be combined as a glycoside, thus enhancing activity, or esterified or oxidized, producing compounds of lower activity; the maximum intensity of the inotropic response was reduced in the less potent compounds; (b) a 14-,1-OH associated with a cis C-D ring junction, alteration of which abolished activity; (c) an unsaturated cyclobutenolide ring which cannot be reduced without a great decrease in activity. Current knowledge about the relationship between chemical structure and pharma- cological activity in the cardiac glycosides is derived principally from the work of Chen and his colleagues (see review by Chen, 1945; Chen & Henderson, 1954), who tested more than 200 naturally occurring cardiac glycosides, aglycones and their derivatives for toxicity in the cat. Toxicity in the frog after injection into the lymph sac (Chen, Chen & Anderson, 1936; Chen & Elderfield, 1940, 1942; Chen, Elderfield, Uhle'& Fried, 1943) and the concentration that produced systolic standstill in the isolated frog heart (Chen, Steldt, Fried & Elderfield, 1942) were also tested for some of the compounds.
    [Show full text]
  • International
    IM versily Microfilms International » t / I2'5 2.2 If £ U& u. u i.i IriUU 1.8 1.25 1.4 ssssssss 1.6 MICROCOPY RESOLUTION TEST CHART w. NATIONAL BUREAU OF STANDARDS Si, STANDARD REFERENCE MATERIAL 1010a (ANSI and ISO TEST CHART No. 2) \ University Microfilms Inc 300 N. Zecb Road, Ann Arbor, M I 48106 INFORMATION TO USERS This reproduction was made from a copy of a manuscript sent to us for publication and microfilming. While the most advanced technology has been used to pho­ tograph and reproduce this manuscript, the quality of the reproduction is heavily dependent upon the quality of the material submitted. Pages in any manuscript may have indistinct print. In all cases the best available copy has been filmed. The following explanation of techniques is provided to help clarify notations which may appear on this reproduction. 1. Manuscripts may not always be complete. When it is not possible to obtain missing pages, a note appears to indicate this. 2. When copyrighted materials are removed from the manuscript, a note ap­ pears to indicate this. 3. Oversize materials (maps, drawings, and charts) are photographed by sec­ tioning the original, beginning at the upper left hand comer and continu­ ing from left to right in equal sections with small overlaps. Each oversize page is also filmed as one exposure and is available, for an additional charge, as a standard 35mm slide or in black and white paper format.* 4. Most photographs reproduce acceptably on positive microfilm or micro­ fiche but lack clarity on xerographic copies made from the microfilm.
    [Show full text]
  • Digoxigenin Biotinylated Antibody
    Digoxigenin Biotinylated Antibody Monoclonal Mouse IgG2A Clone # 611621 Catalog Number: BAM7520 DESCRIPTION Specificity Detects Digoxigenin labeled proteins, nucleic acids and Digoxigenin conjugated primary and secondary antibodies. Source Monoclonal Mouse IgG2A Clone # 611621 Purification Protein A or G purified from hybridoma culture supernatant Immunogen KLH­coupled Digoxigenin Formulation Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. See Certificate of Analysis for details. APPLICATIONS Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website. Recommended Sample Concentration Immunohistochemistry 8­25 µg/mL See Below DATA Immunohistochemistry Netrin­4 was detected in perfusion fixed frozen sections of mouse brain (nucleus accumbens) using Goat Anti­Mouse Netrin­4 Antigen Affinity­purified Polyclonal Antibody (Catalog # AF1132) conjugated to Digoxigenin at 15 µg/mL overnight at 4 °C. Tissue was stained using the Digoxigenin Biotinylated Monoclonal Antibody (brown; Catalog # BAM7520) at 3 μg/mL followed by Streptavidin­HRP incubation. Specific staining was localized to vasculature. View our protocol for Chromogenic IHC Staining of Frozen Tissue Sections. PREPARATION AND STORAGE Reconstitution Sterile PBS to a final concentration of 0.5 mg/mL. Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. Stability & Storage Use a manual defrost freezer and avoid repeated freeze­thaw cycles. l 12 months from date of receipt, ­20 to ­70 °C as supplied. l 1 month, 2 to 8 °C under sterile conditions after reconstitution. l 6 months, ­20 to ­70 °C under sterile conditions after reconstitution.
    [Show full text]
  • Digoxigenin Sheep Polyclonal Antibody – BP419 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for BP419 Digoxigenin Sheep Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: ELISA, IHC, WB Recommended Dilution: ELISA (1/100-1/5,000). Western blot. Immunohistochemistry on Frozen Tissue. Host: Sheep Clonality: Polyclonal Immunogen: Digoxin-3-CMO conjugated to KLH Specificity: The antibody recognizes Digoxigenin. It cross reacts with Digoxin and Digitoxin. Negligible reactivity has been observed with Ouabain. Formulation: PBS containing 0.09% Sodium Azide as preservative. State: Purified State: Liquid purified IgG fraction. Concentration: lot specific Purification: Affinity Chromatography on Protein G . Conjugation: Unconjugated Storage: Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Stability: Shelf life: one year from despatch. This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 Digoxigenin Sheep Polyclonal Antibody – BP419 Background: Digoxigenin is a steroid found in plants that is often attached to oligonucleotides and used as a molecular probe to detect mRNA production. Digoxigenin (DIG) is a steroid found exclusively in the flowers and leaves of the plants Digitalis purpurea and Digitalis lanata. Digoxigenin is chemically closely related to Digoxin, the cardiac glycoside used for the treatment of various heart diseases. The term 'genin' at the end of Digoxigenin, refers to only the aglycone portion (without the sugar) part of the molecule,thus Digoxigenin is the steroid component of Digoxin, - minus the (digitose) sugar residues.
    [Show full text]
  • 1 510(K) SUBSTANTIAL EQUIVALENCE DETERMINATION
    510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE A. 510(k) Number: k082953 B. Purpose for Submission: New device C. Measurand: Digoxin D. Type of Test: Quantitative E. Applicant: Biokit S.A. F. Proprietary and Established Names: ARCHITECT iDigoxin Reagents ARCHITECT iDigoxin Calibrators G. Regulatory Information: Product Code Classification Regulation Section Panel KXT Class II 862.3320 91, Toxicology DLJ Class II 862.3200 91, Toxicology H. Intended Use: 1. Intended use(s): See Indications for Use below. 1 2. Indication(s) for use: The ARCHITECT iDigoxin assay is an in vitro chemiluminescent microparticle immunoassay (CMIA) for the quantitative measurement of digoxin in human serum or plasma on the ARCHITECT i System with STAT protocol capability. The measurements obtained are used to aid in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to help ensure appropriate therapy. The ARCHITECT iDigoxin Calibrators are for the calibration of the ARCHITECT i System with STAT protocol capability when used for the quantitative determination of digoxin in human serum or plasma. For in vitro diagnostic use 3. Special conditions for use statement(s): For prescription use only 4. Special instrument requirements: ARCHITECT i System I. Device Description: The ARCHITECT iDigoxin assay is an in vitro chemiluminescent microparticle immunoassay (CMIA) for the quantitative measurement of digoxin in human serum or plasma on the ARCHITECT i System with STAT protocol capability. The measurements obtained are used to aid in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to help ensure appropriate therapy. Each iDigoxin Reagent kit contains 1 bottle of each component of Microparticles, Conjugate and Assay Diluent.
    [Show full text]
  • I. in Situ Hybridization with DIG-Labeled Probes
    DIG_InSitu_ManualCover_RZ 30.07.2008 17:28 Uhr Seite 3 C M Y CM MY CY CMY K DIG Application Manual for Nonradioactive In Situ Hybridization 4th Edition Probedruck DIG_InSitu_ManualCover_RZ 30.07.2008 17:28 Uhr Seite 4 C M Y CM MY CY CMY K Intended use Our preparations are exclusively intended to be used in life science research applications.* They must not be used in or on human beings since they were neither tested nor intended for such utilization. Preparations with hazardous substances Our preparations may represent hazardous substances to work with. The dangers which, to our knowledge, are involved in the handling of these preparations (e.g., harmful, irritant, toxic, etc.), are separately mentioned on the labels of the packages or on the pack inserts; if for certain preparations such danger references are missing, this should not lead to the conclusion that the corresponding preparation is harmless. All preparations should only be handled by trained personnel. Preparations of human origin The material has been prepared exclusively from blood that was tested for Hbs antigen and for the presence of antibodies to the HIV-1, HIV-2, HCV and found to be negative. Nevertheless, since no testing method can offer complete assurance regarding the absence of infectious agents, products of human origin should be handled in a manner as recommended for any potentially infectious human serum or blood specimen. Liability The user is responsible for the correct handling of the products and must follow the instructions of the pack insert and warnings on the label. Roche Diagnostics shall not assume any liability for damages resulting from wrong handling of such products.
    [Show full text]